☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Regeneron
PharmaShots Weekly Snapshots (April 22 – April 26, 2024)
April 26, 2024
Regeneron and Mammoth Collaborate for CRISPR Gene Editing Therapies Against Multiple Diseases
April 26, 2024
Biocon Enters into an Exclusive License Agreement with Bayer and Regeneron for the Commercialization of Yesafili (biosimilar, afli...
March 4, 2024
Insights+: EMA Marketing Authorization of New Drugs in January 2024
February 21, 2024
PharmaShots' Key Highlights of Fourth Quarter 2023
January 17, 2024
Bayer and Regeneron Receive the EC’s Approval for Eylea (aflibercept, 8mg) for the Treatment of Age-related Macular Degeneration (...
January 8, 2024
Load more...
Back to Home